-
1321
Alogliptin: a new addition to the class of DPP-4 inhibitors
Published 2009-07-01“…Radha Andukuri, Andjela Drincic, Marc RendellDivision of Endocrinology, Department of Medicine, Creighton University School of Medicine, Omaha, Nebraska, USABackground: Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). …”
Get full text
Article -
1322
Unique Features of Immunity within the Immunoglobulin Heavy Chain Locus of Egyptian Rousette Bats
Published 2020-08-01Get full text
Article -
1323
-
1324
-
1325
Effect of social disparities on 10 year survival in pediatric patients with Wilms' tumor
Published 2023-02-01Get full text
Article -
1326
-
1327
‘Smoke in the air’: a rare cerebrovascular cause of neurological signs and symptoms in a young adult
Published 2015-06-01Get full text
Article -
1328
-
1329
-
1330
-
1331
Tertiary drug information sources for treatment and prevention of COVID-19
Published 2023-10-01Get full text
Article -
1332
-
1333
-
1334
-
1335
Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
Published 2019-11-01Get full text
Article -
1336
-
1337
Incremental healthcare cost burden in patients with atrial flutter only
Published 2023-03-01Get full text
Article -
1338
-
1339
Biomechanical Characterization of Abdominal Aortic Aneurysm: The Rupture Mechanism
Published 2024-01-01Get full text
Article -
1340